12-132657119-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006231.4(POLE):​c.3582+17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.964 in 1,613,426 control chromosomes in the GnomAD database, including 750,395 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 72246 hom., cov: 29)
Exomes 𝑓: 0.96 ( 678149 hom. )

Consequence

POLE
NM_006231.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.11

Publications

8 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 12-132657119-T-C is Benign according to our data. Variant chr12-132657119-T-C is described in ClinVar as Benign. ClinVar VariationId is 380211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.985 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.3582+17A>G
intron
N/ANP_006222.2Q07864

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.3582+17A>G
intron
N/AENSP00000322570.5Q07864
POLE
ENST00000535270.5
TSL:1
c.3501+17A>G
intron
N/AENSP00000445753.1F5H1D6
POLE
ENST00000537064.5
TSL:1
n.*3333+17A>G
intron
N/AENSP00000442578.1F5H7E4

Frequencies

GnomAD3 genomes
AF:
0.975
AC:
148139
AN:
152010
Hom.:
72185
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.993
Gnomad AMI
AF:
0.986
Gnomad AMR
AF:
0.973
Gnomad ASJ
AF:
0.984
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.972
Gnomad FIN
AF:
0.965
Gnomad MID
AF:
0.987
Gnomad NFE
AF:
0.963
Gnomad OTH
AF:
0.968
GnomAD2 exomes
AF:
0.971
AC:
243962
AN:
251156
AF XY:
0.971
show subpopulations
Gnomad AFR exome
AF:
0.993
Gnomad AMR exome
AF:
0.974
Gnomad ASJ exome
AF:
0.982
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.964
Gnomad NFE exome
AF:
0.965
Gnomad OTH exome
AF:
0.971
GnomAD4 exome
AF:
0.963
AC:
1407674
AN:
1461298
Hom.:
678149
Cov.:
45
AF XY:
0.964
AC XY:
700595
AN XY:
726938
show subpopulations
African (AFR)
AF:
0.994
AC:
33281
AN:
33476
American (AMR)
AF:
0.974
AC:
43575
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.984
AC:
25714
AN:
26128
East Asian (EAS)
AF:
1.00
AC:
39679
AN:
39686
South Asian (SAS)
AF:
0.965
AC:
83181
AN:
86242
European-Finnish (FIN)
AF:
0.963
AC:
51273
AN:
53224
Middle Eastern (MID)
AF:
0.984
AC:
5666
AN:
5756
European-Non Finnish (NFE)
AF:
0.960
AC:
1066876
AN:
1111698
Other (OTH)
AF:
0.968
AC:
58429
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2529
5058
7588
10117
12646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21632
43264
64896
86528
108160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.975
AC:
148259
AN:
152128
Hom.:
72246
Cov.:
29
AF XY:
0.975
AC XY:
72472
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.993
AC:
41178
AN:
41484
American (AMR)
AF:
0.973
AC:
14876
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.984
AC:
3416
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5157
AN:
5160
South Asian (SAS)
AF:
0.972
AC:
4677
AN:
4810
European-Finnish (FIN)
AF:
0.965
AC:
10222
AN:
10590
Middle Eastern (MID)
AF:
0.986
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
0.963
AC:
65499
AN:
68012
Other (OTH)
AF:
0.969
AC:
2045
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
190
380
571
761
951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.973
Hom.:
13367
Bravo
AF:
0.976
Asia WGS
AF:
0.986
AC:
3428
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
4
not specified (4)
-
-
1
Colorectal cancer, susceptibility to, 12 (1)
-
-
1
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.30
DANN
Benign
0.31
PhyloP100
-3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5744889; hg19: chr12-133233705; API